Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.

Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.

Charli-Joseph Y, Lima G, Ramos-Bello D, Aguilar D, Orozco-Topete R, Llorente L.

Arch Dermatol Res. 2013 May;305(4):353-7. doi: 10.1007/s00403-012-1305-6. Epub 2012 Dec 8.

PMID:
23224615
2.

Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.

Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S.

Invest Ophthalmol Vis Sci. 2008 May;49(5):1809-13. doi: 10.1167/iovs.07-1401. Epub 2008 Feb 8.

PMID:
18263811
3.

Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.

Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W.

Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8.

PMID:
19696695
4.
5.

A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Tohkin M, Kaniwa N, Saito Y, Sugiyama E, Kurose K, Nishikawa J, Hasegawa R, Aihara M, Matsunaga K, Abe M, Furuya H, Takahashi Y, Ikeda H, Muramatsu M, Ueta M, Sotozono C, Kinoshita S, Ikezawa Z; Japan Pharmacogenomics Data Science Consortium.

Pharmacogenomics J. 2013 Feb;13(1):60-9. doi: 10.1038/tpj.2011.41. Epub 2011 Sep 13.

PMID:
21912425
6.

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Harr T, French LE.

Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39. Review.

7.

A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Cristallo AF, Schroeder J, Citterio A, Santori G, Ferrioli GM, Rossi U, Bertani G, Cassano S, Gottardi P, Ceschini N, Barocci F, Ribizzi G, Cutrupi V, Cairoli R, Rapisarda V, Pastorello EA, Barocci S.

Int J Immunogenet. 2011 Aug;38(4):303-9. doi: 10.1111/j.1744-313X.2011.01011.x. Epub 2011 May 4.

PMID:
21545408
8.

Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.

Chung WH, Hung SI.

J Dermatol Sci. 2012 Jun;66(3):190-6. doi: 10.1016/j.jdermsci.2012.04.002. Epub 2012 Apr 11. Review.

PMID:
22541332
9.

HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.

Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.

Pain Pract. 2012 Mar;12(3):202-8. doi: 10.1111/j.1533-2500.2011.00479.x. Epub 2011 Jun 16.

PMID:
21676164
10.

Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.

Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S.

Br J Ophthalmol. 2008 Jul;92(7):989-91. doi: 10.1136/bjo.2007.136796.

PMID:
18577653
11.

Innate immunity of the ocular surface and ocular surface inflammatory disorders.

Ueta M.

Cornea. 2008 Sep;27 Suppl 1:S31-40. doi: 10.1097/ICO.0b013e31817f2a7f.

PMID:
18813073
12.

Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.

Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.

Br J Dermatol. 2006 Oct;155(4):722-8.

PMID:
16965421
13.

A marker for Stevens-Johnson syndrome ...: ethnicity matters.

Lonjou C, Thomas L, Borot N, Ledger N, de Toma C, LeLouet H, Graf E, Schumacher M, Hovnanian A, Mockenhaupt M, Roujeau JC; RegiSCAR Group.

Pharmacogenomics J. 2006 Jul-Aug;6(4):265-8. Epub 2006 Jan 17.

PMID:
16415921
14.

Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?

Shi YW, Min FL, Qin B, Zou X, Liu XR, Gao MM, Wang Q, Zhou JQ, Liao WP.

Basic Clin Pharmacol Toxicol. 2012 Jul;111(1):58-64. doi: 10.1111/j.1742-7843.2012.00868.x. Epub 2012 Mar 17.

15.

Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.

Chung WH, Hung SI.

Allergol Int. 2010 Dec;59(4):325-32. doi: 10.2332/allergolint.10-RAI-0261. Epub 2010 Oct 25. Review.

16.

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.

Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, Chen YT, Hung SI.

J Allergy Clin Immunol. 2011 Dec;128(6):1266-1276.e11. doi: 10.1016/j.jaci.2011.08.013. Epub 2011 Sep 14.

PMID:
21924464
17.

Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N.

BMC Med Genet. 2011 Sep 9;12:118. doi: 10.1186/1471-2350-12-118. Review.

18.

HLA-A*0206 with TLR3 polymorphisms exerts more than additive effects in Stevens-Johnson syndrome with severe ocular surface complications.

Ueta M, Tokunaga K, Sotozono C, Sawai H, Tamiya G, Inatomi T, Kinoshita S.

PLoS One. 2012;7(8):e43650. doi: 10.1371/journal.pone.0043650. Epub 2012 Aug 17.

19.

Association analysis of cytokine polymorphisms and plasma level in Northern Chinese Han patients with paroxysmal nocturnal hemoglobinuria.

Wang SY, Yang XJ, Yang SS, Wang W, Tian YY, Cao FL, Zhou J.

Chin Med J (Engl). 2012 May;125(9):1576-80.

PMID:
22800824
20.

Role of cytokine gene (interferon-γ, transforming growth factor-β1, tumor necrosis factor-α, interleukin-6, and interleukin-10) polymorphisms in the risk of oral precancerous lesions in Taiwanese.

Hsu HJ, Yang YH, Shieh TY, Chen CH, Kao YH, Yang CF, Ko EC.

Kaohsiung J Med Sci. 2014 Nov;30(11):551-8. doi: 10.1016/j.kjms.2014.09.003. Epub 2014 Oct 27.

Supplemental Content

Support Center